Back to top

UiPath gains as AI product momentum and heavy short interest appear to fuel rally

UiPath, Inc. (PATH) is up 9.2% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver appears to be continued investor interest in UiPath’s agentic automation push, helped by a steady stream of product launches and partnerships over the past several weeks. This could also be because PATH has unusually high short interest, which can magnify buying pressure when sentiment turns positive.

Details:

  • UiPath’s latest quarterly filing and earnings materials showed the company entering fiscal 2027 with ongoing revenue growth, a large cash position, and management guidance that pointed to further annual recurring revenue expansion.
  • In mid-June, the company introduced Maestro Case, a new AI-native case management capability aimed at complex, exception-heavy enterprise workflows, adding to its recent agentic automation product narrative.
  • Earlier in May, UiPath launched native integrations for coding agents, including support for Claude Code and OpenAI Codex, broadening its platform story around enterprise AI orchestration.
  • Latest reported short-interest data show a very large percentage of the public float sold short, which increases the chances that a strong up day becomes more aggressive as short sellers cover.
  • Sources:

    UiPath, SEC, MarketBeat

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $PATH Insider Trading Activity

    PATH Insider Trades

    $PATH insiders have traded $PATH stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.

    Here’s a breakdown of recent trading of $PATH stock by insiders over the last 6 months:

    • DANIEL DINES (CEO and Chairman) has made 0 purchases and 14 sales selling 630,000 shares for an estimated $10,204,204.
    • ASHIM GUPTA (COO & CFO) sold 67,468 shares for an estimated $1,086,497

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

    $PATH Hedge Fund Activity

    We have seen 311 institutional investors add shares of $PATH stock to their portfolio, and 316 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

    $PATH Price Targets

    Multiple analysts have issued price targets for $PATH recently. We have seen 13 analysts offer price targets for $PATH in the last 6 months, with a median target of $13.0.

    Here are some recent targets:

    • Radi Sultan from UBS set a target price of $12.0 on 06/29/2026
    • Keith Bachman from BMO Capital set a target price of $13.0 on 06/01/2026
    • Scott Berg from Needham set a target price of $15.0 on 05/29/2026
    • Sanjit Singh from Morgan Stanley set a target price of $15.0 on 05/29/2026
    • Brad Sills from B of A Securities set a target price of $13.0 on 05/29/2026
    • Lucky Schreiner from DA Davidson set a target price of $12.0 on 05/29/2026
    • Bryan C. Bergin from TD Cowen set a target price of $13.0 on 03/12/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Read full article here »

    In-Depth Zacks Research for the Tickers Above

    Normally $25 each - click below to receive one report FREE:

    UiPath, Inc. (PATH)